| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8725214 | Clinical Gastroenterology and Hepatology | 2018 | 29 Pages |
Abstract
We performed a retrospective analysis of patients with AIH that confirmed the therapeutic value of budesonide beyond 12 months of treatment in patients who are intolerant to or dependent on prednisolone. Although budesonide-induced side effects appear to be mild in real life, effectiveness was limited in a considerable proportion of patients; close monitoring is advised.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Moritz Peiseler, Tina Liebscher, Marcial Sebode, Roman Zenouzi, Johannes Hartl, Hanno Ehlken, Nadine Pannicke, Christina Weiler-Normann, Ansgar W. Lohse, Christoph Schramm,